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To date, only seroepidemiological data are available on the role of human cytomegalovirus (HCMV) in
patients with severe burns. We present the first longitudinal analysis of disseminated HCMV infection with a
demonstration of self-limited productive viral replication identified in both the blood and lung of a burn
patient.
CASE REPORT
An otherwise-healthy, 40-year-old female presented to our
burn center after having suffered a 65% total body-surface-
area self-immolation burn. She sustained full-thickness burns
to her neck, both her arms, her chest, her abdomen, and her
back as well as partial-thickness burns to both upper and lower
extremities. On postburn day 2, a tracheostomy was per-
formed. Subsequently, a fascial excision of all of the full-thick-
ness-burned area was performed, and the area was covered
with glycerol-preserved allogeneic skin (Euroskin; Beverwijk,
The Netherlands). After removal of the cadaver skin, meshed
split-thickness autologous skin was transplanted to both the
arms and the neck. On hospital day 23, after the removal of the
cadaver skin from the patient’s chest and abdomen and the
debrided areas on both legs, these areas were grafted with
cultured epithelial autografts (Epicel; Genzyme Tissue Repair,
Cambridge, MA) simultaneously overlaid on acellular alloge-
neic dermis (AlloDerm; LifeCell Corp., Branchburg, NJ). The
back was grafted with split-thickness autologous micrografts
(1:6; Meek) simultaneously overlaid on Alloderm. All areas of
the skin transplants healed uneventfully, with the exception of
the back. The transplanted area on the back developed a heavy
bacterial colonization with pus and partial graft loss 10 days
after transplantation (postburn day 56). Wound swabs revealed
Staphylococcus epidermidis and Staphylococcus aureus, while
blood cultures stayed negative for bacterial pathogens. As a
result of wound care and intravenous antibiotics, wound heal-
ing without sequelae was observed within 2 days. During the
course of the intensive care unit stay, the patient suffered from
multiple septic episodes (3) with body temperatures of 38°C
or 36°C, tachycardia of 90 beats/min, tachypnea or a need
for mechanical ventilation, and leukocytosis of 12  103
cells/mm3 or 4  103 cells/mm3 (3). Daily chest X rays ex-
cluded any radiological evidence of interstitial pneumonia.
Within the first 3 weeks after the burn, the patient received 32
units of packed red blood cells. The patient was weaned from
the ventilator on hospitalization day 77 and discharged from
the intensive care unit 4.5 months after the injury.
Longitudinal human cytomegalovirus (HCMV) screening
was performed using serology, virus culturing, and nucleic acid
amplification techniques from day 0 to day 120 after the burn
(Fig. 1). Serology was done by anti-HCMV immunoglobulin G
(IgG)/IgM enzyme-linked immunosorbent assay (DiaSorin,
Du¨sseldorf, Germany). Virus culturing was performed by con-
ventional tube cell culturing of bronchoalveolar lavage (BAL)
fluids, throat swabs, urine samples, and skin biopsy specimens.
Nested PCR with leukocytes, plasma, BAL fluids, throat swabs,
and skin biopsy specimens was performed using primer se-
quences from the HCMV immediate-early region exon 4 (8).
Quantitative HCMV DNA was detected with a COBAS AM-
PLICOR CMV MONITOR test (Roche Diagnostics), and
qualitative HCMV late pp67 mRNA was screened by nucleic
acid sequence-based amplification (Organon Teknika, Boxtel,
The Netherlands) (5) from blood and BAL fluids.
The initial serostatus of the patient was unknown. On day 0,
HCMV DNA was not detectable in serum. Fluctuating HCMV
IgG levels resulted from the transfusion of multiple blood
products. HCMV IgM seroconversion was initially observed on
postburn day 25, when the patient was septic (3). The patient
suffered from disseminated HCMV infection with viral leuko-
cyte and plasma DNAemia. The peak level of the viral load was
noted on postburn day 39 and was greater than 10,000 copies
of HCMV DNA/ml plasma. Viral replication in blood was
productive from day 21 to day 45 after the burn, as confirmed
by the simultaneous detection of late viral RNA (Fig. 1). Low
viral DNA levels were detectable in plasma for an additional
week. The retrospectively analyzed course of the plasma viral
DNA load described a unimodal kinetics (Fig. 1). Antiviral
treatment was not performed. Despite the lack of radiological
signs of interstitial pneumonia, both viral DNA and late viral
RNA were detectable simultaneously in BAL fluids. Addition-
ally, viral isolates from BAL fluids and viral DNA from throat
swabs were also obtained during this time. Interestingly, pro-
ductive viral replication in the lung seemed to persist for nearly
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1 month longer than observed in the blood. Therefore, viral
RNA and infectious virus could be isolated from BAL fluids as
late as postburn day 71 (Fig. 1).
Very little data are available on the role of HCMV as an
etiological factor for disease in the thermally injured patient.
With the exception of one study (2), most of these reports are
anecdotal or based on seroepidemiological studies (1, 4, 10, 11,
17, 18). In human burn patients, HCMV may potentially be
transmitted by skin allografts, as shown by the manifestation of
HCMV infection in initially seronegative burn patients grafted
with cadaver allografts for temporary wound closure (12). The
prevalence of herpesvirus infections (HCMV and herpes sim-
plex virus type 1) in patients with severe burn injuries was
estimated to be 52% (10). A significant correlation between
herpesvirus infections and bacterial sepsis was found (10), but
HCMV or herpes simplex virus type 1 infections did not con-
tribute significantly to the morbidity and mortality of burn
patients (1, 10, 11). In contrast, more-detailed data on the
immune response of thermally injured mice against murine
cytomegalovirus infection have recently become available,
showing evidence of a significant contribution of murine cyto-
megalovirus infection to morbidity and mortality (13–15).
To our knowledge, this is the first case of a productive
HCMV infection with documented viral DNAemia and
RNAemia in a patient with severe burns. The involvement of
the lung could be demonstrated convincingly by the detection
of viral DNA, viral RNA, and infectious virus from BAL fluids.
This report demonstrates that HCMV infections in burn
patients may well have been underdiagnosed in the past. The
self-limited dynamics of viral DNAemia and viral RNAemia
may explain several of the former clinical observations and
suggest the minor importance of HCMV infection relative to
overall mortality. However, the presence of highly productive
HCMV replication in the blood and lung of a severely injured
burn patient in the context of several septic episodes and
prolonged mechanical ventilation warrants further investiga-
tion of these findings in a clinical trial, as HCMV reactivation
in nonimmunosuppressed critically ill patients with acute sepsis
has a high prevalence (9). More-detailed data are necessary to
characterize the influence of septic episodes on the dynamics
of HCMV replication (6, 7, 16).
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